Cytosorbents Corporation provided preliminary unaudited revenue guidance for the fourth quarter and full year 2017. For the year, the Company expects total revenue in excess of $15 million. Full year 2017 CytoSorb sales of approximately $13.2 million (range $13.1 million to 13.3 million), representing more than 60% growth from $8.2 million in 2016. For the quarter, the company expects total revenue of approximately $4.6 million.